RACK1 and breast carcinoma: Thus, we reveal a novel mode of interaction between PSMD2, RACK1 and β-catenin, that may be a mechanism involved in regulating the activation of the WNT pathway, and targeting this pathway may be an effective way to treat breast cancer.